Today’s market demands speed, flexibility, and innovation to address today’s new challenges. As a result, pharmaceutical and biotechnology companies face increasing pressure to bring blockbuster drugs to market quickly and cost-effectively. Selecting the right partner is critical to bringing a drug to market—on time, and on budget. Outsourcing eliminates the need to maintain expensive in-house facilities while providing access to a broad range of different technologies and expertise.
This whitepaper outlines the vital six-point criteria that pharmaceutical and biotechnology companies should follow when looking to select the ideal partner to synthesize their API and ensure their drug development process stays on the path to success.